Advisory Services Network’s BioCryst Pharmaceuticals BCRX Stock Holding History

Advisory Services Network’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.08K	Buy	+428	New	+$3.32K	﹤0.01%	3936
2025 Q4	–	Sell	-7,500	Closed	-$56.9K	–	2045
2025 Q3	$56.9K	Sell	7,500 -28,801	-79%	-$240K	﹤0.01%	2394
2025 Q2	$295K	Buy	+36,301	New	+$338K	﹤0.01%	1418
2024 Q1	–	Sell	-3,740	Closed	-$22.4K	–	1666
2023 Q4	$22.4K	Buy	+3,740	New	+$21.7K	﹤0.01%	2469
2023 Q2	–	Sell	-4,740	Closed	-$39.5K	–	1654
2023 Q1	$39.5K	Buy	4,740 +1,500	+46%	+$14.4K	﹤0.01%	2153
2022 Q4	$37.2K	Buy	+3,240	New	+$40.4K	﹤0.01%	2139
2021 Q3	–	Sell	-4,850	Closed	-$77K	–	1562
2021 Q2	$77K	Buy	+4,850	New	+$65.9K	﹤0.01%	1760
2021 Q1	–	Sell	-5,700	Closed	-$42K	–	1457
2020 Q4	$42K	Hold	5,700	–	–	﹤0.01%	1761
2020 Q3	$20K	Buy	+5,700	New	+$24.4K	﹤0.01%	2080
2020 Q2	–	Sell	-5,700	Closed	-$11K	–	1199
2020 Q1	$11K	Hold	5,700	–	–	﹤0.01%	2163
2019 Q4	$20K	Buy	5,700 +1,700	+43%	+$4.28K	﹤0.01%	2005
2019 Q3	$15K	Hold	4,000	–	–	﹤0.01%	1949
2019 Q2	$15K	Hold	4,000	–	–	﹤0.01%	1947
2019 Q1	$33K	Hold	4,000	–	–	﹤0.01%	1393
2018 Q4	$32K	Sell	4,000 -500	-11%	-$3.89K	﹤0.01%	1307
2018 Q3	$34K	Hold	4,500	–	–	﹤0.01%	1370
2018 Q2	$26K	Sell	4,500 -2,000	-31%	-$11K	﹤0.01%	1449
2018 Q1	$31K	Hold	6,500	–	–	﹤0.01%	1487
2017 Q4	$32K	Hold	6,500	–	–	﹤0.01%	1446
2017 Q3	$34K	Hold	6,500	–	–	﹤0.01%	1232
2017 Q2	$36K	Hold	6,500	–	–	﹤0.01%	1155
2017 Q1	$55K	Buy	+6,500	New	+$45.2K	0.01%	963
2016 Q3	$31K	Sell	7,000 -3,500	-33%	-$14K	0.01%	1002
2016 Q2	$30K	Buy	10,500 +4,600	+78%	+$14.3K	0.01%	919
2016 Q1	$17K	Buy	+5,900	New	+$26.1K	﹤0.01%	937
2015 Q3	–	Sell	-7,303	Closed	-$106K	–	1507
2015 Q2	$106K	Buy	+7,303	New	+$83K	0.03%	365
2014 Q3	–	Sell	-30,903	Closed	-$394K	–	262
2014 Q2	$394K	Buy	+30,903	New	+$301K	0.17%	146
2014 Q1	–	Sell	-7,732	Closed	-$59K	–	257
2013 Q4	$59K	Buy	+7,732	New	+$49K	0.03%	298